{"title":"Vonoprazan为基础的双重和三重疗法根除幽门螺杆菌","authors":"J. Noh, Kee Don Choi","doi":"10.7704/kjhugr.2023.0022","DOIUrl":null,"url":null,"abstract":"Article: Vonoprazan Triple and Dual Therapy for Helicobacter pylori Infection in the United States and Europe: Randomized Clinical Trial (Gastroenterology 2022;163:608-619","PeriodicalId":22895,"journal":{"name":"The Korean Journal of Helicobacter and Upper Gastrointestinal Research","volume":null,"pages":null},"PeriodicalIF":0.0000,"publicationDate":"2023-09-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Vonoprazan-based Dual and Triple Therapy for Helicobacter pylori Eradication\",\"authors\":\"J. Noh, Kee Don Choi\",\"doi\":\"10.7704/kjhugr.2023.0022\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Article: Vonoprazan Triple and Dual Therapy for Helicobacter pylori Infection in the United States and Europe: Randomized Clinical Trial (Gastroenterology 2022;163:608-619\",\"PeriodicalId\":22895,\"journal\":{\"name\":\"The Korean Journal of Helicobacter and Upper Gastrointestinal Research\",\"volume\":null,\"pages\":null},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2023-09-15\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"The Korean Journal of Helicobacter and Upper Gastrointestinal Research\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.7704/kjhugr.2023.0022\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"The Korean Journal of Helicobacter and Upper Gastrointestinal Research","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.7704/kjhugr.2023.0022","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
Vonoprazan-based Dual and Triple Therapy for Helicobacter pylori Eradication
Article: Vonoprazan Triple and Dual Therapy for Helicobacter pylori Infection in the United States and Europe: Randomized Clinical Trial (Gastroenterology 2022;163:608-619